2012
DOI: 10.1016/j.biomaterials.2012.01.064
|View full text |Cite
|
Sign up to set email alerts
|

Long-term changes to in vitro preserved bioengineered human trachea and their implications for decellularized tissues

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
69
0
3

Year Published

2012
2012
2022
2022

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 79 publications
(75 citation statements)
references
References 40 publications
3
69
0
3
Order By: Relevance
“…To date, several ECM products have been used or tested in multiple clinical applications [Badylak et al, 2009]. In the lab, whole-organ ECM scaffolds with intact 3D anatomical structures and vasculature conduits have been generated from the heart, lungs, liver, kidneys, pancreas and other organs [Baiguera et al, 2012;Bonvillain et al, 2012;Jeng et al, 2013;Mirmalek-Sani et al, 2013;O'Neill et al, 2013]. Studies have shown that ECM scaffold acquired by decellularization can be repopulated with cells, cultured as a whole-organ construct and partially restore organ function after orthotopic transplantation Totonelli et al, 2012;Qu et al, 2013;Ren et al, 2013].…”
Section: Discussionmentioning
confidence: 99%
“…To date, several ECM products have been used or tested in multiple clinical applications [Badylak et al, 2009]. In the lab, whole-organ ECM scaffolds with intact 3D anatomical structures and vasculature conduits have been generated from the heart, lungs, liver, kidneys, pancreas and other organs [Baiguera et al, 2012;Bonvillain et al, 2012;Jeng et al, 2013;Mirmalek-Sani et al, 2013;O'Neill et al, 2013]. Studies have shown that ECM scaffold acquired by decellularization can be repopulated with cells, cultured as a whole-organ construct and partially restore organ function after orthotopic transplantation Totonelli et al, 2012;Qu et al, 2013;Ren et al, 2013].…”
Section: Discussionmentioning
confidence: 99%
“…This is because it is of paramount importance that both decellularised scaffolds and recellularised, bioengineered replacements can be stored for prolonged periods of time prior to clinical use. For example, Baiguera et al [18] studied the effects of long-term (1 year) storage on both the microstructure and mechanical properties of human decellularised tracheas. To investigate the impact of storing the samples at 4…”
Section: Resultsmentioning
confidence: 99%
“…The ideal method of decellularisation remains to be determined, with differences seen in structural integrity and ECM composition between the three most popular protocols (139). Tissue heterogeneity due to long-term storage prior to surgical implantation is another caveat that must be taken into account (140). Finally, there is the risk of disease transmission between donor and recipient.…”
Section: Decellularised Tissuementioning
confidence: 99%